메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Corero Network Security Selected by XLC to Bolster DDoS Defenses Across New APAC Sites

LONDON, Oct. 16, 2025 -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), a recognized leader in DDoS protection and champion of adaptive, real-time service availability, today announced that XLC has selected Corero to deploy on-premises DDoS protection across five new Asia-Pacific sites, reinforcing its commitment to uninterrupted service and resilient infrastructure for its high-demand customers. XLC, known for its enterprise-grade network infrastructure and hosting solutions, supports mission-critical workloads across fintech, gaming, and media streaming. The company requi
- 황정호 기자
- 2025-10-16 07:00
ALVAREZ & MARSAL LAUNCHES IN JAPAN WITH HIRING OF SIX MANAGING DIRECTORS TO STEER SERVICE SUITE OFFERING

Firm opens offices in Tokyo and Osaka as demand grows for differentiated consulting services TOKYO and OSAKA, Japan, Oct. 16, 2025 -- Leading global professional services firm Alvarez & Marsal ("A&M") announces its formal footprint in Japan with new offices in Tokyo and Osaka and the hiring of 14 professionals, including six Managing Directors and eight supporting staff, all hailing from the market's largest competitor firms. A&M's expansion into Japan ("A&M Japan") underpins the firm's continued build of service points in Asia's financial h
- 황정호 기자
- 2025-10-16 06:19
Alvarez & Marsal日本に進出― 6名のマネージング・ディレクターを迎えサービス提供体制を強化

差別化されたコンサルティングサービスへの需要拡大を受け、東京・大阪にオフィスを開設東京・大阪, 2025年10月16日 -- 世界有数のプロフェッショナルサービスファームであるAlvarez & Marsal（以下「A&M」）は、日本での事業展開を正式に開始し、東京および大阪にオフィスを開設しました。日本での事業展開にあたり、A&Mは業界を代表するファームで豊富な実績を持つマネージング・ディレクター6名を含む14名の体制を整えました。今回の「A&M Japan」設立は、アジアの主要金融ハブにおけるA&Mのプレゼンス拡大の一貫であり、日本市場における多様化したコンサルティングサービスへのニーズの高まりに応えるものです。 A&Mは40年以上にわたり、経営改善、事業再編及びアドバイザリー分野において確かな実績を築いてきました。A&M Japanは、まずM&A関連実務に深い知見を持つ専門チームを立ち上げて事業を開始し、国内外の財務・会計・税務・コーポレートファイナンスの分野で専門的なサービスを提供します。今後は、事業再編およびバリューアップ分野のニーズに応えるべく、体制をさらに拡充していく予定です。 A&M Japanの設立に際し、グローバルトランザクション
- 황정호 기자
- 2025-10-16 06:00
트라이넷엑스, 동료 심사 연구에서 가장 많이 인용된 실사용 데이터 출처로 부상

2000건 이상 인용•연간 80% 성장… 트라이넷엑스(TriNetX), 경쟁사 앞서며 주요 의학 저널의 과학 연구 뒷받침 케임브리지, 매사추세츠, 2025년 10월 15일 -- '연결된 세계'를 비전으로 인공지능과 데이터로 인간의 건강 향상을 이끄는 트라이넷엑스(TriNetX)가 동료 심사 학술지에서 가장 많이 인용된 전자건강기록(EHR) 데이터셋으로 자리매김했다. 이번 결과는 2025년 8월 27일 기준 PubMed 데이터를 분석한 최신 조사를 통해 확인됐다. 이번 분석에 따르면, 전 세계 임상 연구자, 공중보건 기관, 의료기관의 트라이넷엑스 데이터 사용이 급증했다. 총 2025건의 인용을 기록했으며, 이는 가장 가까운 경쟁사(149건)보다 약 1300% 높은 수치로, 실사용 증거(real-world evidence) 생성에 있어 트라이넷엑스의 역할이 빠르게 확대되고 있음을 보여준다. 연도별 인용 건수도 급격히 증가했다. 2021년 96건에서 2024년 707건으로 늘었으며, 2025년 1~8월 사이에만 952건이 인용됐다. 이러한 추세라면 트라이넷엑스는 올해 처음으로 연간 1000건 이상의 인용을 달성
- 김갑성 기자
- 2025-10-16 05:47
PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement

[ 메디채널 김갑성 기자 ] Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy MONTVALE, N.J., Oct. 16, 2025 -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, for the acquisition of the C2 CryoBalloon™ technology. This strategic move allows PENTAX Medical to sharpen its focus on core endoscopic solutions while fostering deeper clinical partnerships. The C2 CryoBal
- 김갑성 기자
- 2025-10-16 04:05
GIGABYTE Announces Availability of GAMING A16 PRO and GAMING A18 Laptops

TAIPEI, Oct. 16, 2025 -- GIGABYTE, the world's leading computer brand, officially announces the global availability of its next-gen gaming laptops—the GAMING A16 PRO and GAMING A18. Expanding the 2025 GAMING Series lineup, both models combine uncompromised power with portable design, featuring up to NVIDIA® GeForce RTX™ 5080 Laptop GPUs and GIGABYTE's exclusive GiMATE AI Agent. With over 12 hours of battery life, these ultra-slim laptops deliver intelligent performance and immersive experiences for gamers and creators alike. Built for hybrid gaming and AI workflows, the GAM
- 김장윤(JASON KIM) 기자
- 2025-10-16 00:00
SJinn Shatters AI Video Limits, Integrating Sora2 and Veo3 for Minute-Long, Character-Consistent Storytelling

[ 메디채널 김장윤(JASON KIM) 기자 ] Revolutionary integration allows for minute-long video generation with flawless character consistency, unlocking true cinematic storytelling for creators worldwide. SAN FRANCISCO, Oct. 15, 2025 -- SJinn AI, a pioneer in automated video production, today announced a groundbreaking update to its platform: the successful integration of the advanced Sora2 and Veo3 models. This enhancement shatters the industry's sub-10-second clip limitation, empowering creators to generate minute-long videos with flawless character consistency for the first time. While
- 김장윤(JASON KIM) 기자
- 2025-10-15 23:30
Taiwan Launches 2025 "Taiwan Weeks" to Advance its Position as Asian Asset Management Center

TAIPEI, Oct. 15, 2025 -- Taiwan officially launched its inaugural "Taiwan Weeks" on Wednesday, marking a significant step in its determination to become a leading asset management center in Asia. The two-week program was opened by the Financial Supervisory Commission (FSC) Chairman Peng Jin-lung and attracted participation from over 150 listed companies, more than 100 financial institutions, and nearly 80 representatives from global exchanges and institutional investors. The event is led by the FSC and co-organized by the Taiwan Stock Exchange (TWSE), Taipei Exchange, Taiwan
- 황정호 기자
- 2025-10-15 23:20
Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline

BEIJING and SHANGHAI and BOSTON, Oct. 15, 2025 -- Jacobio Pharma (1167.HK) today announced that its subsidiary, Beijing Jacobio Pharmaceuticals Co., Ltd. ("Beijing Jacobio"), has entered into a Capital Increase and Equity Transfer Agreement with Oceanpine Capital and an industry partner. Under the agreement, Oceanpine Capital will acquire 80% equity interest in Beijing Jacoray Pharmaceutical Technology Co., Ltd. ("Jacoray") for a total consideration of RMB 200 million (comprising RMB 125 million as the upfront payment and an additional RMB 75 million as a second instalment
- 김갑성 기자
- 2025-10-15 23:05
Advanced Instruments is Now Merged Under the Nova Biomedical Name: One Unified Brand Driving Innovation

WALTHAM, Mass., Oct. 15, 2025 -- We are proud to announce that Advanced Instruments and Nova Biomedical are now officially doing business under a single, unified brand. This is a transformative moment in our journey to deliver greater value to customers across the biopharmaceutical and clinical markets. Starting today we will be also unveiling a refreshed brand identity and logo across the merged organization that reflects our forward-looking vision and deep commitment to innovation. This strategic merger brings together two industry leaders with complementary strengths in anal
- 김갑성 기자
- 2025-10-15 22:36

이전

51 52 53 54 55 56 57 58 59 60

많이 본 기사

최근기사

2025-10-30_THU

2025-10-29_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 30일 08시 20분